See more : Orient Overseas (International) Limited (OROVY) Income Statement Analysis – Financial Results
Complete financial analysis of Syra Health Corp. Class A Common Stock (SYRA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Syra Health Corp. Class A Common Stock, a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Weibo Corporation (9898.HK) Income Statement Analysis – Financial Results
- Speed Rabbit Pizza SA (MLSRP.PA) Income Statement Analysis – Financial Results
- BEST AGROLIFE LIMITED (BESTAGRO.BO) Income Statement Analysis – Financial Results
- Shipping Corporation of India Land and Assets Limited (SCILAL.NS) Income Statement Analysis – Financial Results
- PANABYTE TECHNOLOGIES LIMITED (PANABYTE.BO) Income Statement Analysis – Financial Results
Syra Health Corp. Class A Common Stock (SYRA)
About Syra Health Corp. Class A Common Stock
Syra Health Corp., a healthcare services company, provides health education, population health management, behavioral and mental health, healthcare workforce, and digital health services in the United States. It offers health education services, including medical communications, patient education, and healthcare training; and population health management services, such as analytics as a service, epidemiology, and health equity analytics solutions. The company also engages in developing Syrenity, an on-demand telehealth platform for mental health services. In addition, the company provides healthcare staffing solutions; and digital health solutions comprising digital transformation, cloud and security, artificial intelligence, patient engagement, and health apps. It serves mental health hospitals and organizations, including government agencies, integrated health networks, managed care entities, and pharmaceutical manufacturers. Syra Health Corp. was incorporated in 2020 and is headquartered in Carmel, Indiana.
| Metric | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 5.52M | 5.62M | 1.41M | 0.00 |
| Cost of Revenue | 4.10M | 4.56M | 979.62K | 0.00 |
| Gross Profit | 1.41M | 1.06M | 430.35K | 0.00 |
| Gross Profit Ratio | 25.60% | 18.90% | 30.52% | 0.00% |
| Research & Development | 240.05K | 0.00 | 0.00 | 0.00 |
| General & Administrative | 4.01M | 3.11M | 416.01K | 0.00 |
| Selling & Marketing | 0.00 | 390.27K | 39.59K | 0.00 |
| SG&A | 4.01M | 3.11M | 416.01K | 4.27K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 4.30M | 3.15M | 433.63K | 4.27K |
| Cost & Expenses | 8.40M | 7.71M | 1.41M | 4.27K |
| Interest Income | 2.94K | 63.00 | 0.00 | 0.00 |
| Interest Expense | 53.69K | 28.53K | 0.00 | 0.00 |
| Depreciation & Amortization | 48.77K | 14.85K | 207.00 | 51.20K |
| EBITDA | -2.84M | -2.07M | -3.07K | -4.27K |
| EBITDA Ratio | -51.42% | -36.93% | -0.22% | 0.00% |
| Operating Income | -2.89M | -2.09M | -3.28K | -4.27K |
| Operating Income Ratio | -52.36% | -37.20% | -0.23% | 0.00% |
| Total Other Income/Expenses | -50.74K | -28.47K | 0.00 | -46.93K |
| Income Before Tax | -2.94M | -2.12M | -3.28K | -4.27K |
| Income Before Tax Ratio | -53.28% | -37.71% | -0.23% | 0.00% |
| Income Tax Expense | 0.00 | 63.00 | 0.00 | -51.20K |
| Net Income | -2.94M | -2.12M | -3.28K | -4.27K |
| Net Income Ratio | -53.28% | -37.71% | -0.23% | 0.00% |
| EPS | -0.60 | -0.36 | 0.00 | 0.00 |
| EPS Diluted | -0.60 | -0.29 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 4.88M | 5.86M | 7.28M | 5.98M |
| Weighted Avg Shares Out (Dil) | 4.88M | 7.28M | 7.28M | 5.98M |
Syra Health Launches Syrenity: An Evidence-Based App for Managing Common Mental Health Conditions
Syra Health to Present at NobleCon20
Syra Health Delivers Third Quarter 2024 Financial Results
Syra Health To Discuss Third Quarter 2024 Financial Results
Syra Health is Awarded New Healthcare Workforce Contracts Across Multiple States
Syra Health Marks First Anniversary as a Publicly Traded Company with Strong Successes and Growth
Syra Health Announces Closing of $2.1 Million Public Offering
Syra Health Announces Pricing of $2.1 Million Public Offering
Syra Health Announces Second Quarter 2024 Financial Results, Led by Strong Revenue Growth of 101%
Syra Health To Discuss Second Quarter 2024 Financial Results
Source: https://incomestatements.info
Category: Stock Reports